Population variation in VKORC1 haplotype structure

This publication has 7 references indexed in Scilit:

• Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population
  Pharmacogenetics and Genomics, 2005
• The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen
  Blood, 2005
• Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin Dose
  New England Journal of Medicine, 2005
• The Influence of Ethnicity on Warfarin Dosage Requirement
  Annals of Pharmacotherapy, 2005
• A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
  Blood, 2005
• Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and γ-glutamyl carboxylase) gene variants with warfarin sensitivity
  Blood, 2004
• Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin
  Thrombosis and Haemostasis, 2004